China’s Blue Sail Medical Co., Ltd (SHE: 002382) has announced that Blue Sail Biosensors Medical Technology, its wholly-owned subsidiary, has introduced a strategic investor, Beijing Daxing Airport Economic Zone Development Fund. The fund has made a substantial investment of RMB 100 million (USD 14 million) in the company.
The proceeds from this investment will be directed towards bolstering product research and development, enhancing production capacity, and supporting the company’s day-to-day operations.- Flcube.com
